Paul H Ehrlich

Title: Inventor Paul H. Ehrlich - Pioneering Antibody Fragment Compositions

Introduction

Paul H. Ehrlich, based in White Plains, NY, is an accomplished inventor known for his significant contributions to the field of immunology. With a focus on antibody fragment compositions, Ehrlich has made strides in developing novel immunologically active compounds designed to enhance therapeutic efficiency.

Latest Patents

Ehrlich holds a patent for "Antibody Fragment Compositions and Process." This innovative patent details a method for producing immunologically active rabbit IgG antibody fragment compositions. The process involves isolating the anti-light variable chain of rabbit IgG and/or the anti-heavy variable chain of rabbit IgG. These chains are then combined either with each other or with the complementary heavy or light chain of rabbit IgG, creating versatile and effective antibody fragments that are crucial for research and therapeutic applications.

Career Highlights

Currently, Paul H. Ehrlich works at the Massachusetts General Hospital Corporation. His dedication to research and innovation has positioned him as a vital player in the advancement of immunological therapies. His academic and professional journey reflects a relentless pursuit of knowledge and improvement in medical science.

Collaborations

Ehrlich has collaborated with notable colleagues in his field, including Gary R. Matsueda and Michael N. Margolies. These partnerships highlight his commitment to fostering collaboration within the scientific community, enabling the exchange of ideas that drive advancements in therapeutic research.

Conclusion

Paul H. Ehrlich's contributions through his patent and collaborative work exemplify the critical role inventors play in the ongoing evolution of medical science. His dedication to developing antibody fragment compositions not only enhances our understanding of immunology but also paves the way for future innovations in therapeutic treatments.